Unitree IPO 5,550 Times Oversubscribed As UBS Says Grey Market Points To 3.5x Open
The global market leader in humanoid-robot shipments, China-based Unitree, is set to begin trading on Shanghai’s STAR Market on Wednesday, potentially sparking a wave of robotics listings in Asia as the race for physical AI remains in its early innings.
Unitree New Robot Preview: “Superman” Breaking the Limits of Humanity
Standing high jump 2 m, top speed 12.66 m/s (0.85 m leg length)
Surpassing the standing high jump and running speed records of all humans around the world
This new machine has only been in development for a… pic.twitter.com/12i80ITU6p— Unitree (@UnitreeRobotics) August 17, 2026
The Wall Street Journal reported that the Hangzhou-based company raised $900 million after pricing its shares at 150.80 yuan apiece, implying a valuation of about $9.1 billion. Retail demand was off the charts, with investors submitting 9.8 million orders and the offering more than 5,500 times oversubscribed.
“Unitree’s IPO is significant because it provides an important A-share valuation benchmark for embodied AI and humanoid robotics,” Morningstar analyst Kangyuxiao Li said.
Jacqueline Du, Goldman’s head of China Industrial Technology research, recently explained that Unitree is the global market leader in humanoid-robot shipments:
Global Market Leader: In 2025, Unitree shipped more than 5,500 humanoid robots, capturing a 37% global market share, according to Omdia.
This volume far outstripped Western peers such as Tesla, Figure AI, and Agility Robotics, each of which shipped around 150 humanoid robots in 2025, according to public reports cited by Omdia.
That said, this leadership was achieved during the very early stages of the humanoid-robot industry, where technology is evolving rapidly and the competitive landscape remains fluid.
Wednesday’s IPO gives mainland investors direct exposure to one of China’s top robotics companies and could pave the way for future listings by its domestic competitors.
UBS analyst Tony Chalmers noted:
Unitree is set for its first day of trading on the STAR Board on Aug. 19 at a CNY61 bn market cap, or 219x PS, with a free float of only ~30 mn shares, representing 7.4% of total shares. The grey market is pointing to a ~3.5x open.
The pre-IPO perpetual contract on the Hyperliquid platform – not Unitree stock or IPO allocation – is about $99.50 per contract; the market implies a Unitree valuation near $40 billion, based on roughly 404.5 million post-IPO shares. That is more than four times the reported $9.1 billion IPO valuation.
In markets, the Solactive China Humanoid Robotics Index (Bloomberg ticker: SOLCHRBP Index), which tracks publicly traded Chinese companies involved in the humanoid-robotics supply chain, is down 18% year to date.
SOLCHRBP covers robot manufacturers and suppliers of AI systems, actuators, motion controls, sensors, automation equipment, and other components.
Goldman’s Du highlighted how Unitree’s pricing advantage is mostly underpinned by “China’s supply-chain advantages.” Unitree offers robots priced from roughly $4,000 to $100,000, compared with about $150,000 to $1 million for Boston Dynamics models.
Unitree founders understood something the US robotics industry did not.
A robot engineers can afford to buy, break, modify, and buy again can create a much larger market than a perfect robot nobody can afford and people watch videos of online.
So Unitree shipped “Laikago” in… pic.twitter.com/GxHElhuOKG
— Gabriel (@gabriel_horwitz) August 18, 2026
Readers should not be surprised that China is leading the humanoid-robotics race. We have outlined this trend on multiple occasions (see here).
The U.S. invented the robot dog.
China is about to dominate the market.
Tomorrow Unitree starts trading at a $9bn valuation after selling 23,000 quadrupeds last year. We had a 15-year head start.
This is how America turned a research lead into a manufacturing loss…
pic.twitter.com/lTBtmWmTv4
— Gabriel (@gabriel_horwitz) August 18, 2026
The big question is whether President Trump can close the gap, given that the US lacks the fully integrated supply chains needed to manufacture critical components, including rare-earth magnets and actuators that power these robots.
Tyler Durden Tue, 08/18/2026 – 17:20
Source: https://freedombunker.com/2026/08/18/unitree-ipo-5550-times-oversubscribed-as-ubs-says-grey-market-points-to-3-5x-open/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.







